Literature DB >> 2116634

Pregnancy and medical cost outcomes of a self-help prenatal smoking cessation program in a HMO.

D H Ershoff1, V P Quinn, P D Mullen, D R Lairson.   

Abstract

The results of a randomized clinical trial of a prenatal self-help smoking cessation program are reported in terms of the pregnancy and cost outcomes. The study population were the socioeconomically and ethnically diverse members of a large health maintenance organization (HMO) who reported that they were smoking at the time of their first prenatal visit. The intervention consisted predominantly of printed materials received through the mail. Compared with the usual care control group, women assigned to the self-help program were more likely to achieve cessation for the majority of their pregnancy (22.2 percent versus 8.6 percent), gave birth to infants weighing on average 57 grams more, and were 45 percent less likely to deliver a low birth weight infant. An economic evaluation of the self-help program was conducted from the perspective of the sponsoring HMO. Based upon the expenditures associated with the neonates' initial hospital episode, the intervention had a benefit-cost ratio of 2.8:1. These findings provide strong evidence to support widespread incorporation of smoking cessation interventions as a standard component of prenatal care.

Entities:  

Mesh:

Year:  1990        PMID: 2116634      PMCID: PMC1580090     

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  12 in total

1.  A randomized trial of a serialized self-help smoking cessation program for pregnant women in an HMO.

Authors:  D H Ershoff; P D Mullen; V P Quinn
Journal:  Am J Public Health       Date:  1989-02       Impact factor: 9.308

2.  Maternal smoking during pregnancy and expenditures on neonatal health care.

Authors:  G Oster; T E Delea; G A Colditz
Journal:  Am J Prev Med       Date:  1988 Jul-Aug       Impact factor: 5.043

3.  Comparing the prevalence of smoking in pregnant and nonpregnant women, 1985 to 1986.

Authors:  D F Williamson; M K Serdula; J S Kendrick; N J Binkin
Journal:  JAMA       Date:  1989-01-06       Impact factor: 56.272

4.  The effectiveness of smoking cessation methods for smokers in public health maternity clinics: a randomized trial.

Authors:  R A Windsor; G Cutter; J Morris; Y Reese; B Manzella; E E Bartlett; C Samuelson; D Spanos
Journal:  Am J Public Health       Date:  1985-12       Impact factor: 9.308

5.  Behavioral, health, and cost outcomes of an HMO-based prenatal health education program.

Authors:  D H Ershoff; N K Aaronson; B G Danaher; F W Wasserman
Journal:  Public Health Rep       Date:  1983 Nov-Dec       Impact factor: 2.792

6.  A clinical trial of change in maternal smoking and its effect on birth weight.

Authors:  M Sexton; J R Hebel
Journal:  JAMA       Date:  1984-02-17       Impact factor: 56.272

7.  Effect of anti-smoking health education on infant size at birth: a randomized controlled trial.

Authors:  C MacArthur; J R Newton; E G Knox
Journal:  Br J Obstet Gynaecol       Date:  1987-04

8.  The cost-effectiveness of counseling smokers to quit.

Authors:  S R Cummings; S M Rubin; G Oster
Journal:  JAMA       Date:  1989-01-06       Impact factor: 56.272

9.  Smoking in pregnancy: effects of stopping at different stages.

Authors:  C MacArthur; E G Knox
Journal:  Br J Obstet Gynaecol       Date:  1988-06

10.  A cost-effectiveness analysis of self-help smoking cessation methods for pregnant women.

Authors:  R A Windsor; K E Warner; G R Cutter
Journal:  Public Health Rep       Date:  1988 Jan-Feb       Impact factor: 2.792

View more
  23 in total

Review 1.  The limited incorporation of economic analyses in clinical practice guidelines.

Authors:  Joel F Wallace; Scott R Weingarten; Chiun-Fang Chiou; James M Henning; Andriana A Hohlbauch; Margaret S Richards; Nicole S Herzog; Lior S Lewensztain; Joshua J Ofman
Journal:  J Gen Intern Med       Date:  2002-03       Impact factor: 5.128

Review 2.  Does smoking by pregnant women influence IQ, birth weight, and developmental disabilities in their infants? A methodological review and multivariate analysis.

Authors:  M C Ramsay; C R Reynolds
Journal:  Neuropsychol Rev       Date:  2000-03       Impact factor: 7.444

Review 3.  Cost effectiveness of smoking-cessation therapies. Interpretation of the evidence-and implications for coverage.

Authors:  K E Warner
Journal:  Pharmacoeconomics       Date:  1997-06       Impact factor: 4.981

4.  The health benefits of smoking cessation for adult smokers and for pregnant women in Taiwan.

Authors:  C P Wen; T Y Cheng; C-L Lin; H-N Wu; D T Levy; L-K Chen; C-C Hsu; M P Eriksen; H-J Yang; S P Tsai
Journal:  Tob Control       Date:  2005-06       Impact factor: 7.552

5.  Defining reducible risk : Social dimensions of assessing birth technologies.

Authors:  S B Ruzek
Journal:  Hum Nat       Date:  1993-12

6.  Integrating individual and public health perspectives for treatment of tobacco dependence under managed health care: a combined stepped-care and matching model.

Authors:  D B Abrams; C T Orleans; R S Niaura; M G Goldstein; J O Prochaska; W Velicer
Journal:  Ann Behav Med       Date:  1996

Review 7.  Economic implications of smoking cessation therapies: a review of economic appraisals.

Authors:  D R Cohen; G H Fowler
Journal:  Pharmacoeconomics       Date:  1993-11       Impact factor: 4.981

8.  Understanding maternal smoking during pregnancy: does residential context matter?

Authors:  Carla Shoff; Tse-Chuan Yang
Journal:  Soc Sci Med       Date:  2012-12-01       Impact factor: 4.634

9.  Estimation of the break-even point for smoking cessation programs in pregnancy.

Authors:  M Shipp; M S Croughan-Minihane; D B Petitti; A E Washington
Journal:  Am J Public Health       Date:  1992-03       Impact factor: 9.308

Review 10.  A review of economic evaluations of tobacco control programs.

Authors:  Jennifer W Kahende; Brett R Loomis; Bishwa Adhikari; Latisha Marshall
Journal:  Int J Environ Res Public Health       Date:  2008-12-28       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.